211734-87-1 Usage
Uses
Used in Pharmaceutical Industry:
2H-Benzimidazol-2-one,5,6-difluoro-1,3-dihydro-1-methyl-,hydrazone(9CI) is used as an intermediate in the synthesis of pentacyclic fluoroquinolines, which are a class of compounds with significant potential in the development of new drugs. These pentacyclic fluoroquinolines exhibit a range of biological activities, including antimicrobial, anticancer, and anti-inflammatory properties, making them valuable for the treatment of various diseases and conditions.
In the pharmaceutical industry, 2H-Benzimidazol-2-one,5,6-difluoro-1,3-dihydro-1-methyl-,hydrazone(9CI) plays a crucial role in the development of novel therapeutic agents. Its unique chemical structure allows for the creation of new molecules with improved pharmacological properties, such as enhanced potency, selectivity, and reduced side effects. 2H-Benzimidazol-2-one,5,6-difluoro-1,3-dihydro-1-methyl-,hydrazone(9CI)'s versatility in chemical synthesis enables researchers to explore a wide range of structural modifications, leading to the discovery of innovative drug candidates with improved therapeutic profiles.
Furthermore, 2H-Benzimidazol-2-one,5,6-difluoro-1,3-dihydro-1-methyl-,hydrazone(9CI) can also be utilized in the development of drug delivery systems, where its chemical properties can be exploited to enhance the solubility, stability, and bioavailability of the resulting pharmaceuticals. This can lead to more effective treatments with reduced dosing requirements and minimized side effects, ultimately benefiting patients and healthcare providers alike.
Check Digit Verification of cas no
The CAS Registry Mumber 211734-87-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,1,7,3 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 211734-87:
(8*2)+(7*1)+(6*1)+(5*7)+(4*3)+(3*4)+(2*8)+(1*7)=111
111 % 10 = 1
So 211734-87-1 is a valid CAS Registry Number.
211734-87-1Relevant articles and documents
SMALL MOLECULE REGULATORS OF STEROID RECEPTOR COACTIVATORS AND METHODS OF USE THEREOF
-
Paragraph 0277; 0281; 0282; 0283; 0287, (2017/10/27)
Small molecule regulators of steroid receptor coactivator (SRC) family proteins are provided, as well as methods for their use in treating or preventing SRC-related diseases. The SRC-related diseases can include cancer, metabolic disorders, human immunodeficiency virus, neurodegenerative disorders, and/or inflammatory diseases. Also provided are methods for regulating SRC family proteins in a cell.
Synthesis and Cyclization of Derivatives of 3-Heterylhydrazino-2-polyfluorobenzoylacrylic Acid
Lipunova,Mokrushina,Nosova,Chasovskikh,Rusinova,Aleksandrov
, p. 1476 - 1486 (2007/10/03)
Cyclization of ethyl esters of 3-heterylhydrazino-2-polyfluorobenzoylacrylic acid results either to 2-(5-polyfluorophenyl-4-ethoxycarbonylpyrazol-1-yl)benzazoles or 2-(4-polyfluorobenzoyl-5-ethoxypyrazol-1-yl)benzenes or, in the case of benzimidazolyl derivatives possessing NH fragment, to derivatives of benzimidazolo[1,2-a]pyrazolo[1,5-c]quinazoline, a new heterocyclic system.
